Original Paper
2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Heart Disease
Victor L. Lazaro1
- Summary
- Supplementary Material
- References
- About this Article
Abstract
In 2009, the Philippine Heart Association (PHA) Council on Coronary Artery Disease (CAD) published the Philippine Clinical Practice Guidelines (CPG) on CAD, which included guidelines on chronic stable angina pectoris (CSAP), unstable angina or non-ST elevation myocardial infarction (UA/NSTEMI), and ST-elevation myocardial infarction (STEMI).
Keywords
Percutaneous Coronary Intervention - Acute Coronary Syndrome - Clopidogrel - Coronary Artery Bypass Grafting - Coronary Compute Tomographic Angiography
Supplementary Material
Nil
References
1. Philippine Heart Association. 2009 PHA Clinical Practice Guidelines for the Management of Coronary Artery Disease. Quezon City: Philippine Heart Association, 2009.
2.E SC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom- Lundqvist C, Borger MA, et al. Eur Heart J. 2012 Oct;33(20):2569–619.
3. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 29;127(4):e362–425. PubMed
4. Yaneza LO, Abanilla JM, Abola MTB, Caole-Ang IV, Fernandez MBD, Lopez EA, Punzalan FER, Reyes EB; Steering Committee Members for the Philippine Heart Association-Acute Coronary Syndrome (PHA-ACS) Registry. Philippine Heart Association-Acute Coronary Syndrome Registry: 2 year Results. Phil J Cardiol 2013;2 (in press).
5. ISIS-2 (Second International Study of lnfarct Survival) Collaborative Group. Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17 187 Cases of Suspected Acute Myocardial Infarction: ISIS-2. Lancet 1988;332(8607):349–360. CrossRef
6. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al.; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005 Nov 5;366(9497):1607–21. CrossRef PubMed
7. Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, et al.; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fi brinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005 Mar 24;352(12):1179–89.
8. Mehta SR, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J. 2000 Dec;21(24):2033–41. CrossRef PubMed
9. Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, et al.; TRITON-TIMI 38 Investigators. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006 Oct;152(4):627–35. CrossRef PubMed
10. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al.; for the PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045–1057. CrossRef PubMed
11. Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare metal stents in patients with acute myocardial infarction. Eur Heart J 2007;28: 2706–2713. CrossRef PubMed
12. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557–563. CrossRef PubMed
13. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549–556.
14. Belliard G, Catez E, Charron C, Caille V, Aegerter P, Dubourg O, et al. efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation. Resuscitation 2007;75:252–259. CrossRef PubMed
15. Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, et al.; American Heart Association. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 Nov 2;122(18 Suppl 3):S768–86.
16. Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O’Dea D, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005;19:33–39. CrossRef PubMed
17. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary. Circulation. 1998; 97: 1325–1335.
18. Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant FC, Tu JV, Alter DA. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol 2003;41:1573–1582. CrossRef PubMed
19. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986 Jul 12;2(8498):57–66.
20. Metoprolol in acute myocardial infarction. Narcotic analgesics and other antianginal drugs. The MIAMI Trial Research Group. Am J Cardiol. 1985 Nov 22;56(14):30G–34G. CrossRef
21. Pizarro G, Fernández-Friera L, Fuster V, Fernández- Jiménez R, García- Ruiz JM, García-Álvarez A, et al. Long-Term Benefit of Early Pre- Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction: Results From the METOCARD-CNIC Trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J Am Coll Cardiol. 2014 Jun 10;63(22):2356–62. CrossRef PubMed
22. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al.; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001 Jan 24-31;285(4):430–6. CrossRef
23. Stenestrand U, Wallentin L; Swedish Register of Cardiac Intensive Care (RIKS-HIA). Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001 Apr 4;285(13):1711–8. CrossRef
24. ISIS-4(Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction”, The Lancet 1995;345 (8951):669–682. CrossRef
25. GISSI-3 Group. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. The Lancet. 1994. 343(8906):1115–22.
26. Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS- 1) Collaborative Group. Chin Med J (Engl). 1997 Nov;110(11):834–8.
27. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al.; Cholesterol Treatment Trialists' (CTT) Collaborators. efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005 Oct 8;366(9493):1267–78.
28. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 1992 Sep 3;327(10):678–84. CrossRef PubMed
29. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, et al.; Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003 Nov 13;349(20):1893–906. CrossRef PubMed
30. Ovricenco E, Sinescu C, Dinescu S. Effect of angiotensin II type 1 receptor antagonist valsartan on cardiac remodeling and left ventricular function in patients with acute ST-elevation myocardial infarction. J Med Life. 2008 Jul- Sep;1(3):323–33. PubMed
31. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991;67:1295–1297.
32. Steg P, Lopez-de-Sà E, Schiele F, Hamon M, Meinertz T, Goicolea J, et al.; VIVIFY (eValuation of the Intra Venous If inhibitor ivabradine after STsegment elevation mYocardial infarction) investigators. Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study. Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):270-9. CrossRef
33. Fasullo S, Cannizzaro S, Maringhini G, Ganci F, Giambanco F, Vitale G, et al. Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings. J Card Fail. 2009 Dec;15(10):856–63. CrossRef PubMed
34. Lawler PR, Filion KB, Eisenberg MJ. efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and metaanalysis of randomized controlled trials. Am Heart J 2011;162(4):571-584 e57–2. CrossRef PubMed
About this Article
Title2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Heart Disease
Open Access
Available under Open Access
Journal
>> ASEAN Heart Journal
>> 24:1
Online Date
21 November 2019
DOI
10.7603/s40602-016-0003-6
Online ISSN
2315-4551
Publisher
ASEAN Federation of Cardiology
Additional Links
Topics
Cardiology
Keywords
Percutaneous Coronary Intervention
Acute Coronary Syndrome
Clopidogrel
Coronary Artery Bypass Grafting
Coronary Compute Tomographic Angiography
Author Affiliations
1. Philippine Heart Association, Pasig, Philippine
Correspondence to Victor L. Lazaro, secretariat@philheart.org